Oscar Health, Inc. SEC filings OSCR

Oscar Health, Inc. has 587 filings in SEC EDGAR's recent list, going back to Sep 11, 2013. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Oscar Health, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
4 Insider transaction Sep 22, 2026 Sep 18, 2026
4 Insider transaction Sep 18, 2026 Sep 18, 2026
4 Insider transaction Sep 18, 2026 Sep 18, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 18, 2026 —
144 Notice of proposed sale Sep 18, 2026 —
8-K Current report
Regulation FD disclosure
Sep 16, 2026 Sep 16, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Aug 31, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 28, 2026 —
144 Notice of proposed sale Aug 27, 2026 —
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 20, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 13, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
4 Insider transaction Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure
Jun 8, 2026 Jun 8, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 2, 2026 —
8-K Current report
Officer or director change
Jun 2, 2026 May 29, 2026
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 18, 2026 —
4 Insider transaction May 18, 2026 May 14, 2026
144 Notice of proposed sale May 14, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 22, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure
Apr 21, 2026 Apr 21, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
8-K Current report
Regulation FD disclosure
Mar 2, 2026 Mar 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
S-8 Employee stock plan registration Feb 13, 2026 —
10-K Annual report Feb 13, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, New debt
Feb 10, 2026 Feb 6, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 30, 2025 Dec 24, 2025
8-K Current report
Officer or director change
Dec 29, 2025 Dec 22, 2025
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Other events
Nov 6, 2025 Nov 3, 2025
4 Insider transaction Oct 14, 2025 Oct 9, 2025
4 Insider transaction Oct 14, 2025 Oct 9, 2025
4 Insider transaction Oct 14, 2025 Oct 9, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 22, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 18, 2025 Sep 18, 2025
8-K Current report
Agreement ended, Other events
Sep 16, 2025 Sep 15, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Sep 15, 2025 Sep 15, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
8-K Current report
Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2025 —
8-K Current report
Results of operations
Jul 22, 2025 Jul 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jul 14, 2025 Jul 10, 2025
4 Insider transaction Jul 14, 2025 Jul 10, 2025
4 Insider transaction Jul 14, 2025 Jul 10, 2025
144 Notice of proposed sale Jun 20, 2025 —
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 4, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
144 Notice of proposed sale May 16, 2025 —
4 Insider transaction May 14, 2025 May 12, 2025
144 Notice of proposed sale May 14, 2025 —
144 Notice of proposed sale May 12, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
144 Notice of proposed sale May 7, 2025 —
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 4, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
144 Notice of proposed sale Mar 10, 2025 —
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 7, 2025 —
144 Notice of proposed sale Mar 5, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
8-K Current report
Regulation FD disclosure
Mar 3, 2025 Mar 3, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
3 Initial insider ownership Feb 26, 2025 Feb 24, 2025
3 Initial insider ownership Feb 26, 2025 Feb 24, 2025
144 Notice of proposed sale Feb 24, 2025 —
S-8 Employee stock plan registration Feb 21, 2025 —
10-K Annual report Feb 20, 2025 Dec 31, 2024
4 Insider transaction Feb 11, 2025 Feb 7, 2025
144 Notice of proposed sale Feb 10, 2025 —
8-K Current report
Results of operations, Officer or director change
Feb 4, 2025 Jan 29, 2025
4 Insider transaction Jan 13, 2025 Jan 9, 2025
4 Insider transaction Dec 9, 2024 Dec 5, 2024
4 Insider transaction Dec 9, 2024 Dec 5, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
OSCR (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1568651
Former names
Oscar Health, Inc. (until Nov 5, 2026); Mulberry Health Inc. (until Dec 17, 2020)

Other Hospital & Medical Service Plans companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.